Search

Research

Autoantibodies to pancreatic islet antigens identify young children at high risk of type 1 diabetes. On a background of genetic susceptibility, islet autoimmunity is thought to be driven by environmental factors, of which enteric viruses are prime candidates.

Research

The National Institute for Clinical Excellence updated guidance for continuous glucose monitoring (CGM) in 2022, recommending that CGM be available to all people living with type 1 diabetes. Manufacturers can trade in the UK with Conformité Européenne (CE) marking without an initial national assessment. The regulatory process for CGM CE marking, in contrast to the Food and Drug Administration (FDA) and Australian Therapeutic Goods Administration (TGA) process, is described.

Read about Professor Tim Jones and Associate Professor Liz Davis, co-directors of the Children's Diabetes Centre.

Browse the published work of the Centre's researchers

News & Events

We are excited to launch this first-of-its-kind Australian study, monitoring glucose levels in Australian children and adolescents who have tested positive to having one or more type 1 diabetes related antibodies but do not yet need treatment with insulin.

News & Events

Consumer Representative Sharon Harvey

Applications are open for our 2025 Honours and Masters Scholarships with the purpose of providing funding for students to develop and support their type 1 diabetes (T1D) related research.

News & Events

Good planning and communication between families and schools is very important to ensure children are safe and supported. With the new school year underway, hear from our Social Work team with their top tips on managing the start of a new school year.

News & Events

The advancement of technology to assist the daily routine of diabetes is extremely helpful. However, it is important to create clear boundaries in the use of technology. Our social work team have some great tips to set up healthy routines.

News & Events

New continuous glucose monitoring system trial